{
  "timestamp": "2026-01-05T07:24:22.359302",
  "trigger": "after_safety_triage",
  "agent_id": "safety_triage",
  "context": {
    "user_assist": {
      "summary": "Follow-up psychiatric visit focused on evaluating treatment response for worsening depressive symptoms, leading to a medication titration and comprehensive suicide risk assessment.",
      "clinical_nature": "follow-up",
      "validation_result": "approved",
      "reasoning": "The session is a standard follow-up post-SSRI initiation (Sertraline 50mg) focusing on persistent severe vegetative and cognitive symptoms of depression (anhedonia, early awakening, functional decline). Safety assessment was initiated due to reported passive death ideation, confirming clinical necessity."
    },
    "safety_triage": {
      "risk_detected": true,
      "clarification_needed": false,
      "clarification_question": "",
      "suggested_answer": "",
      "concerns": [
        {
          "type": "Suicide Risk",
          "severity": "Moderate",
          "evidence": "Sometimes I think they'd be better off without me dragging them down. ... No, no, I wouldn't do that. I couldn't do that to them. But I just wish I could disappear sometimes.",
          "recommended_action": "Patient reports passive death ideation and wishes of disappearance, but explicitly denies active intent or plan. Protective factors (not wanting to hurt family) are present. Requires immediate formal C-SSRS screening and safety plan reinforcement."
        }
      ],
      "summary": "Patient reports significant depressive symptoms, including anhedonia, insomnia, weight loss, and feelings of guilt/failure. **Moderate Suicide Risk** identified based on passive death ideation, though active intent and plan are explicitly denied."
    }
  }
}